IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
about
Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical reviewMapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous systemBroad-spectrum four-dimensional orthogonal electrophoresis: a novel comprehensively feasible system for protein complexomics investigation.Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposureAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.Change in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential.Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newbornSmall-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.Fc-glycosylation of IgG1 is modulated by B-cell stimuli.Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin GThe Serum Immunoglobulin G Glycosylation Signature of Gastric CancerApplications of Multiple Reaction Monitoring to Clinical Glycomics.Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases.Microscale purification of antigen-specific antibodies.NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation.Differential N-Glycosylation Patterns in Lung Adenocarcinoma TissueSerum Glycans as Risk Markers for Non-Small Cell Lung Cancer.Effects of allergic diseases and age on the composition of serum IgG glycome in children.Enrichment strategies in glycomics-based lung cancer biomarker development.Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics.Novel roles for the IgG Fc glycan.Glycopeptide enrichment and separation for protein glycosylation analysis.IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratory.Fc glycan-modulated immunoglobulin G effector functions.Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.A case for protein-level and site-level specificity in glycoproteomic studies of disease.Systems Vaccinology: Applications, Trends, and Perspectives.Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis.Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.
P2860
Q26782025-90F3298A-8C13-4BDF-B0FF-6985DA2F7DF5Q28075974-D18C4B5E-53C3-4818-B312-38F07F8A0C71Q30524725-B57FCF34-1CD4-4F2D-BFE5-29BC84D0B238Q34424997-7649E3DB-3C94-493A-B169-565250F2DB93Q34489424-B2D41CBF-EB6E-418C-9423-42D9565DF620Q34772586-F05924BC-0C38-44D8-9129-AB8D9B160AEDQ34803358-26DB3B7E-86C4-4981-BC54-9D58B48AA5DFQ34826137-50F0917E-4B7C-4366-BA21-A28B96BB7F25Q34994340-956A355E-B4E6-4674-8BFE-2BF40E46190BQ35063963-165E53E1-7B80-44D8-A4E5-4599589A04F3Q35065968-9AF98F39-285A-43D0-83E7-402B576CDA4AQ35447868-662C8B13-4738-493C-8643-D71C4D72616EQ35873009-81B52078-224E-40DD-866E-62B43CECF2AFQ36016305-CBE48F30-330A-4BDA-A321-E458EC81E702Q36157114-12EB19A3-D9F1-4E21-80D7-A8DC97D381ACQ36249961-C2CBB4EB-552F-4702-9652-0D2618D61C9DQ36278033-C4FEA992-3971-471C-811B-9DF50091C68AQ36759054-A6D3C84F-3A1B-4992-8C4B-F088033F9B4BQ37248132-573FEB98-E979-4234-98CD-101446AA0F66Q37446239-279C8911-FF0E-45D3-958E-7F5C400854EDQ37969700-F9C06728-70FD-4DAB-AE95-E99EF2FF7377Q37979848-C3B452F0-E853-4BD6-AC84-E48C990BA054Q38045258-C9C9E6D1-D63C-4E6E-BE0E-643778D9C156Q38115691-B6CC1C9C-E7A3-467A-AF85-D2E0634B4F0CQ38155231-AEE3E165-81F8-4F00-8F58-7180EEC1515EQ38206710-AC783EC7-66B7-401E-AD39-537244858469Q38753771-17591514-A175-45B7-89C2-612F805F35ECQ38786094-28D02C78-047F-4E9E-8D61-F5A14C18BC35Q38807837-92FF1C87-5BBA-4D17-83F7-8AA3CE40CE3EQ41622831-7796DAEB-F44E-459D-90DD-7D656CD114C1Q42069958-C5803753-3F81-47EE-AFA1-BDEEEA2C6EB3Q42124029-E2CBDC72-2336-4F5D-9C29-A51E83A49642Q45945255-17DCD786-B086-4282-A0CF-45324F5A4683Q48210931-6403DED1-0D73-4169-90BA-F86060559031Q52608527-4929C64F-ACBC-4F6D-99F9-91FF5FF8970D
P2860
IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
IgG fc N-glycosylation changes ...... yndrome and myasthenia gravis.
@ast
IgG fc N-glycosylation changes ...... yndrome and myasthenia gravis.
@en
type
label
IgG fc N-glycosylation changes ...... yndrome and myasthenia gravis.
@ast
IgG fc N-glycosylation changes ...... yndrome and myasthenia gravis.
@en
prefLabel
IgG fc N-glycosylation changes ...... yndrome and myasthenia gravis.
@ast
IgG fc N-glycosylation changes ...... yndrome and myasthenia gravis.
@en
P50
P356
P1476
IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis
@en
P2093
André M Deelder
Maurice H J Selman
P304
P356
10.1021/PR1004373
P577
2010-07-30T00:00:00Z